Clinical efficacy of Nimodipine combined with Rosuvastatin calcium tablets in the treatment of hypertensivecerebral hemorrhage
尼莫地平联合瑞舒伐他汀钙片治疗高血压脑出血的临床疗效研究

摘要

目的 研究尼莫地平联合瑞舒伐他汀钙片治疗高血压脑出血的临床疗效。方法 将2022年01月-2023年10月间我院收治的高血压脑出血患者100例随机分为对照组和实验组，并分析不同治疗方式的应用效果。结果 实验组患者其对神经功能、水肿体积以及血肿量的改善均优于对照组，对比炎性因子水平，实验组优于对照组，P＜0.05。并且两组患者的不良反应发生率没有明显的差异性，P＞0.05。结论 尼莫地平联合瑞舒伐他汀钙片的应用能够改善高血压脑出血患者的临床症状，控制疾病的发展，使其神经功能得到良好的调节，患者机体的炎性因子水平明显降低，提高患者的恢复速度和效果，改善患者的生活质量。

Abstract

Objective To study the clinical efficacy of Nimodipine combined with rosuvastatin calcium tablets in the treatment of hypertensive intracerebral hemorrhage.
Methods 100 patients with hypertensive cerebral hemorrhage admitted to our hospital from January 2022 to October 2023 were randomly divided into control group and experimental group, and the application effects of different treatment methods were analyzed.
Results The improvement of nerve function, edema volume and hematoma volume in experimental group was better than that in control group, compared with the level of inflammatory factors, the experimental group was better than the control group, P < 0.05. There was no significant difference in the incidence of adverse reactions between the two groups (P > 0.05).
Conclusion   Nimodipine combined with rosuvastatin calcium tablets can improve the clinical symptoms of patients with hypertensive intracerebral hemorrhage, control the development of the disease, make the neurological function of the patients be well regulated, the level of inflammatory factors in the patients is significantly reduced, improve the recovery speed and effect of patients, and improve the quality of life of patients.